Overview and Scope
Population screening is a process of assessing the prevalence of a particular trait or disease in the entire population or a subgroup of people. The goal of population screening is to accurately predict which individuals in a group are at risk of developing a disease, which is different from diagnostic testing.
Sizing and Forecast
The population screening market size has grown strongly in recent years. It will grow from $27.02 billion in 2023 to $29.12 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to disease prevention initiative, government health policies, rising healthcare costs, increased disease awareness.
The population screening market size is expected to see strong growth in the next few years. It will grow to $37.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, aging population and chronic diseases, integration of ai and data analytics, expansion of screening access. Major trends in the forecast period include advancements in medical technology, genomics and precision screening, telehealth and remote screening, multi-disease screening panels, health equity and accessibility, .
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
Segmentation & Regional Insights
The population screening market covered in this report is segmented –
1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs
North America was the largest region in the population screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp
Major Driver Impacting Market Growth
The rising prevalence of cancer is expected to propel the growth of the population screening market going forward. Cancer is a condition in which specific cells in the human body develop inappropriately and spread to other parts of the human organism. Population screening can help detect cancer early when it is more treatable and has a better prognosis. For instance, according to the American Cancer Society, a US-based voluntary health organization, around 1.96 million new cancer cases are expected to be diagnosed in the US in 2023, an increase from approximately 1.9 million new cases that occurred in 2021. Therefore, the rising prevalence of cancer is driving the growth of the population screening market.
Key Industry Players
Major companies operating in the population screening market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS
The population screening market report table of contents includes:
1. Executive Summary
2. Population Screening Market Characteristics
3. Population Screening Market Trends And Strategies
4. Population Screening Market – Macro Economic Scenario
5. Global Population Screening Market Size and Growth
.
.
.
32. Global Population Screening Market Competitive Benchmarking
33. Global Population Screening Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Population Screening Market
35. Population Screening Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
